US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 36.170
  • +0.010+0.03%
Close Dec 13 16:00 ET
  • 36.170
  • 0.0000.00%
Post 17:48 ET
2.00BMarket Cap33.90P/E (TTM)

Supernus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Supernus Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
157.30M
175.69M
+18.39M
Beat Est.
+2.22%
+14.17%
+11.69%
EPS
0.02
0.69
+0.67
Beat Est.
+106.90%
+337.93%
+3350.00%
Analyst Rating
Buy

Nov 30, 2024

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 141.833M--
--2024/Q4-- / 154.515M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
May 8, 20242024/Q1143.644M / 145.832M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 141.833M--
--2024/Q4-- / 154.515M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
May 8, 20242024/Q1143.644M / 145.832M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

  • Supernus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 4 16:24 ET

  • Supernus Pharmaceuticals | 8-K: Supernus Announces Third Quarter 2024 Financial Results

    Nov 4 16:15 ET

  • Supernus Pharmaceuticals | 8-K: Supernus Announces Second Quarter 2024 Financial Results

    Aug 6 16:38 ET

  • Supernus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data